Cardinal Health
S&P 500
$234.57
-0.61%
Delayed · cached 15 min
Fair value analysis
CAH
Cardinal Health
$234.57
Close used for this calculation
$225.75Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
34/100
Quality radar
Consensus fair value
$225.75
Near FV▼ -3.8% against the close used
Model range $57.77 – $357.54
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$57.77Fair value$225.75Bull$357.54
FairClose
52-week traded range
52W low $147.4752W high $248.61
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
Cardinal Health closed at $234.57, 3.9% above the consensus fair value of $225.75 drawn from 6 valuation models.
Financial DNA score 34/100 — Weak. P/E of 32.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$357.54
+52.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
$144.60
-38.4%
EPS × 20x (sector P/E)
EPS=7.23, Sector P/E=20x
Peter Lynch (PEG)
$57.77
-75.4%
EPS × Growth% (PEG = 1 is fair)
EPS=7.23, g=8%
EV/EBITDA
$210.69
-10.2%
(EBITDA × 14x − Net Debt) ÷ Shares
EBITDA=3.57B
Reverse DCF
$234.57
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 13.7% | Historical: 8%
Margin of Safety
$188.30
-19.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=251.07, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.